KOPRAN
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Kopran along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-0.77₹ -1.15
As on Dec 26, 2025, 4:01 PM IST
Kopran Price Performance
Today's LowToday's High
₹146.80₹151.65
₹149.15
52 Weeks' Low52 Weeks' High
₹123.75₹220.50
₹149.15
Open Price
₹147.55
Prev. Close
₹150.30
Volume
14,005
Over the last 5 years, the share price of Kopran has gained 1.80% CAGR. Over the past year, the corresponding return has been -30.97%.
Kopran’s current P/E of 40.93x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Kopran Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Kopran | 16.48 | 14.95 | -17.51 | -18.81 | -30.97 | -0.39 | 1.80 |
| Sun Pharmaceutical Industries | -1.50 | -2.97 | 5.60 | 2.92 | -6.64 | 19.85 | 23.95 |
| Divi's Laboratories | 0.59 | 0.05 | 8.81 | -2.53 | 9.14 | 23.21 | 11.26 |
| Torrent Pharmaceuticals | 1.71 | 2.10 | 8.24 | 18.54 | 11.91 | 34.57 | 22.34 |
| Cipla | 0.26 | -0.27 | -0.45 | -0.46 | 0.93 | 11.09 | 12.61 |
| Dr. Reddy's Laboratories | -0.82 | 2.68 | -0.45 | -5.35 | -6.35 | 14.32 | 4.04 |
| Lupin | -0.81 | 2.79 | 7.11 | 8.57 | -3.69 | 41.44 | 16.38 |
| Zydus Lifesciences | -0.21 | -1.68 | -10.50 | -6.46 | -4.96 | 29.44 | 13.34 |
| Mankind Pharma | 2.36 | -2.21 | -12.95 | -4.99 | -24.71 | 15.49 | 9.03 |
| Aurobindo Pharma | -0.33 | -0.13 | 9.95 | 7.66 | -3.98 | 40.24 | 5.84 |
| Alkem Laboratories | 0.11 | -3.06 | 0.38 | 13.87 | 2.21 | 21.49 | 13.67 |
| Abbott India | 3.58 | -4.63 | -4.44 | -8.90 | 0.83 | 9.88 | 12.95 |
| Laurus Labs | 6.73 | 10.57 | 20.94 | 61.78 | 89.82 | 41.57 | 25.53 |
| Glenmark Pharmaceuticals | 3.09 | 7.11 | -0.78 | 17.45 | 30.78 | 67.89 | 32.23 |
| Biocon | 0.80 | 0.55 | 11.09 | 12.43 | 14.10 | 14.25 | -3.23 |
| GlaxoSmithKline Pharmaceuticals | -3.62 | -1.12 | -9.98 | -24.61 | 9.73 | 22.76 | 8.76 |
| Anthem Biosciences | -2.60 | 2.76 | -18.98 | -10.80 | -10.80 | -3.74 | -2.26 |
| Ipca Laboratories | 1.58 | 1.92 | 6.12 | 5.53 | -10.09 | 19.10 | 5.77 |
| Ajanta Pharma | 3.14 | 6.93 | 7.95 | 3.81 | -4.03 | 31.35 | 18.99 |
| J B Chemicals & Pharmaceuticals | 1.58 | 2.50 | 8.62 | 1.06 | 0.33 | 23.21 | 28.62 |
Over the last one year, Kopran has declined 30.97% compared to peers like Sun Pharmaceutical Industries (-6.64%), Divi's Laboratories (9.14%), Torrent Pharmaceuticals (11.91%). From a 5 year perspective, Kopran has underperformed peers relative to Sun Pharmaceutical Industries (23.95%) and Divi's Laboratories (11.26%).
Kopran Financials
Kopran Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 134.74 | 142.31 |
| 10 | 132.68 | 138.12 |
| 20 | 134.86 | 137.47 |
| 50 | 147.47 | 145.26 |
| 100 | 158.01 | 155.84 |
| 200 | 171.16 | 172.01 |
Kopran Share Holding Pattern
In the latest quarter, Kopran saw a rise in promoter holding to 44.43%, while DII stake unchanged at 0.00%, FII holding fell to 0.60%, and public shareholding moved up to 54.99% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Kopran Corporate Actions
Date Time | Announcement |
|---|---|
| Nov 12, 2025, 10:53 PM IST | Kopran Ltd - Announcement under Regulation 30 (LODR)-Investor Presentation |
| Nov 12, 2025, 10:29 PM IST | Kopran Ltd - Announcement under Regulation 30 (LODR)-Investor Presentation |
| Nov 12, 2025, 7:52 PM IST | Kopran Ltd - Board Meeting Outcome for Outcome Of Board Meeting |
| Oct 30, 2025, 10:07 PM IST | Kopran Ltd - Board Meeting Intimation for Financial Result Q2 FY 2025-26 |
| Oct 10, 2025, 11:43 PM IST | Kopran Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
About Kopran
Kopran Ltd. is a Public Limited Listed company incorporated on 26/04/1958 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24230MH1958PLC011078 and registration number is 011078. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 271.01 Cr. and Equity Capital is Rs. 48.29 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressParijat House, 1076, Dr. E. Moses Road, Mumbai Maharashtra 400018
- Contact
Management
- Mr. Susheel G SomaniChairman
- Mr. Surendra SomaniExecutive Vice Chairman
- Mr. Adarsh SomaniDirector
- Mr. Varun SomaniDirector
- Dr. Siddhan SubramanianIndependent Director
- Dr. Sunita BanerjiIndependent Director
- Mrs. Mamta BiyaniIndependent Director
- Mr. Narayan AtalIndependent Director
FAQs on Kopran Share Price
What is the share price of Kopran?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Kopran is ₹149.15 as on Dec 26, 2025.
What kind of stock is Kopran?
The Kopran is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Kopran?
The market cap of Kopran is ₹720.18 Cr as on Dec 26, 2025.
What are today's High and Low prices of Kopran?
Today’s highest and lowest price of Kopran are ₹151.65 and ₹146.80.
What are the 52 Week High and 52 Week Low of Kopran?
The 52-week high/low is the highest and lowest price at which Kopran stock has traded in the past 52-week or nearly a year. The 52-week high of Kopran is ₹220.50 and 52-week low of Kopran is ₹123.75 as on Dec 26, 2025.
How has the Kopran performed historically in terms of returns?
The Kopran has shown returns of -0.77% over the past day, 14.95% for the past month, -17.51% over 3 months, -30.97% over 1 year, -0.39% across 3 years, and 1.8% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Kopran?
P/E ratio of and PB ratio of Kopran are 40.93 and 1.44 on Dec 26, 2025. While the company gives a dividend yield of 2.01 per annum.
✕
Market Pulse